These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9757563)

  • 21. (-)-Indolactam V activates protein kinase C and induces changes in muscarinic receptor functions in SH-SY5Y human neuroblastoma cells.
    Heikkilä J; Akerman KE
    Biochem Biophys Res Commun; 1989 Aug; 162(3):1207-13. PubMed ID: 2764930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological activities and cellular uptake studies of fluorescent derivatives of indole alkaloid tumor promoter teleocidin.
    Irie K; Okuno S; Koshimizu K; Tokuda H; Nishino H; Iwashima A
    Int J Cancer; 1989 Mar; 43(3):513-9. PubMed ID: 2538401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphine inhibits indolactam V-induced U937 cell adhesion and gelatinase secretion.
    Weeks BS; Goldman S; Touma S; Payne M; Cadet P; Stefano GB
    J Cell Physiol; 2001 Nov; 189(2):179-88. PubMed ID: 11598903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and tumor-promoting activities of 12-Epi-phorbol-12,13-dibutyrate.
    Irie K; Nakahara A; Ikawa Y; Tanaka M; Nakagawa Y; Nakamura Y; Ohigashi H; Wender PA
    Biosci Biotechnol Biochem; 2000 Nov; 64(11):2429-36. PubMed ID: 11193412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Syntheses and biological activities of photolabile indolactam derivatives; new probes for the receptor analysis of tumor promoters.
    Okuno S; Irie K; Nishino H; Iwashima A; Koshimizu K
    Agric Biol Chem; 1990 Jul; 54(7):1885-7. PubMed ID: 1368594
    [No Abstract]   [Full Text] [Related]  

  • 26. Modeling, chemistry, and biology of the benzolactam analogues of indolactam V (ILV). 2. Identification of the binding site of the benzolactams in the CRD2 activator-binding domain of PKCdelta and discovery of an ILV analogue of improved isozyme selectivity.
    Kozikowski AP; Wang S; Ma D; Yao J; Ahmad S; Glazer RI; Bogi K; Acs P; Modarres S; Lewin NE; Blumberg PM
    J Med Chem; 1997 Apr; 40(9):1316-26. PubMed ID: 9135029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward the development of new medicinal leads with selectivity for protein kinase C isozymes.
    Irie K; Nakagawa Y; Ohigashi H
    Chem Rec; 2005; 5(4):185-95. PubMed ID: 16041745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcium dependence of indolactam-mediated contractions in resistance vessels.
    Hill MA; Davis MJ; Song J; Zou H
    J Pharmacol Exp Ther; 1996 Mar; 276(3):867-74. PubMed ID: 8786563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PKC activity and protein phosphorylation in regulation of sIg mediated B cell activation.
    Lindsberg ML; Feuerstein N; Balapure AK; Mond JJ
    Scand J Immunol; 1995 Feb; 41(2):194-201. PubMed ID: 7863266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolism of indole alkaloid tumor promoter, (-)-indolactam V, which has the fundamental structure of teleocidins, by rat liver microsomes.
    Hagiwara N; Irie K; Tokuda H; Koshimizu K
    Carcinogenesis; 1987 Jul; 8(7):963-5. PubMed ID: 3109758
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanistic Insights into the P450 TleB-Catalyzed Unusual Intramolecular C-N Bond Formation Involved in the Biosynthesis of Indolactam V.
    Wei J; Liu Y
    J Chem Inf Model; 2021 Jul; 61(7):3638-3648. PubMed ID: 34240606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of 7,8-disubstituted benzolactam-V8 and its binding to protein kinase C.
    Ma D; Zhang T; Wang G; Kozikowski AP; Lewin NE; Blumberg PM
    Bioorg Med Chem Lett; 2001 Jan; 11(2):99-101. PubMed ID: 11206480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylpendolmycin, an indolactam from a Nocardiopsis sp.
    Sun HH; White CB; Dedinas J; Cooper R; Sedlock DM
    J Nat Prod; 1991; 54(5):1440-3. PubMed ID: 1800642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
    Basu A
    Mol Pharmacol; 1998 Jan; 53(1):105-11. PubMed ID: 9443937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams.
    Endo Y; Yokoyama A
    Bioorg Med Chem Lett; 2000 Jan; 10(1):63-6. PubMed ID: 10636245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB; Enyedy IJ; Qiao L; Zhao L; Ma D; Pearce LL; Lorenzo PS; Stone JC; Blumberg PM; Wang S; Kozikowski AP
    J Med Chem; 2002 Feb; 45(4):853-60. PubMed ID: 11831896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding selectivity of conformationally restricted analogues of (-)-indolactam-V to the C1 domains of protein kinase C isozymes.
    Masuda A; Irie K; Nakagawa Y; Ohigashi H
    Biosci Biotechnol Biochem; 2002 Jul; 66(7):1615-7. PubMed ID: 12224655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total syntheses of indolactam alkaloids (-)-indolactam V, (-)-pendolmycin, (-)-lyngbyatoxin A, and (-)-teleocidin A-2.
    Nathel NF; Shah TK; Bronner SM; Garg NK
    Chem Sci; 2014 Jun; 5(6):2184-2190. PubMed ID: 24839542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Manipulation of prenylation reactions by structure-based engineering of bacterial indolactam prenyltransferases.
    Mori T; Zhang L; Awakawa T; Hoshino S; Okada M; Morita H; Abe I
    Nat Commun; 2016 Mar; 7():10849. PubMed ID: 26952246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor promoter binding of the protein kinase C C1 homology domain peptides of RasGRPs, chimaerins, and Unc13s.
    Irie K; Masuda A; Shindo M; Nakagawa Y; Ohigashi H
    Bioorg Med Chem; 2004 Sep; 12(17):4575-83. PubMed ID: 15358285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.